source of aluminium exposure is from aluminiumcontaining phosphate binders as this may remain the Background. Aluminium toxicity in dialysis patients is well described. Aluminium has a close chemical affinity only binder that can effectively control hyperphosphataemia and consequent renal osteodystrophy. with silicon. Silicon may have a role in protection against aluminium toxicity.
Introduction
lysis patients, all were using reverse-osmosis units in the preparation of their dialysate fluids. All centres used calciumAluminium toxicity in dialysis patients is well based phosphate binders as the default preference, with aluminium hydroxide binders added where phosphate control described. It can cause severe bone disease, encephalowas deemed inadequate. Data on individual aluminium phospathy and resistant anaemia. Aluminium has a close phate binder intake was not available. Serum and tap water chemical affinity with silicon, the two elements intersamples were analysed for silicon by direct current plasma acting in an aqueous environment to form hydroxyaluemission spectrometry [6 ] . Dialysate measurements were minosilicates [1] . In many dialysis patients the major limited to the London home patients not on reverse osmosis, as our own studies as well as previous studies [7] were measured by flameless atomic absorption spectrometry [8, 9] . Statistical analysis of grouped data expressed as median (range) was by Mann-Whitney U-test, and linear regression analysis was used to examine the relationship between normally distributed paired data [10] .
Results
The median serum aluminium and silicon concentrations were 0.93 (0.09-9.63) mmol/l and 77 (22-375) mmol/l respectively. The variation between the four centres is shown in Figure 1a group in the 10 years leading up to this study, whereas serum silicon levels in these patients correlated with dialysate silicon. Roberts and Williams [6 ] 
high concentrations of silicon in patients with chronic renal failure compared to healthy subjects. They found Discussion that despite reverse osmosis dialysis (dialysate silicon <1 mmol/l ) certain haemodialysis patients had markedly high silicon levels (>100 mmol/l ), suggesting dietWe have demonstrated a very good relationship between dialysate silicon and serum levels in the ary sources to be significant. Our study adds to this observation as many of the patients had significantly London home haemodialysis patients indicating that the dialysate is the major source of silicon for patients elevated silicon levels despite having been exposed only to dialysate prepared from reverse osmosis treated not using reverse osmosis. In addition, a serum silicon concentration below 150 mmol/l was, in this subgroup water. Together with more recent evidence from D'Haese et al.
[16 ], our results confirm the importance of patients, associated with a significantly higher serum aluminium concentration. In the group as a whole (all of both dialysate and dietary sources of silicon in determining plasma concentrations. In fact, the mean centres) no patient had serum aluminium concentrations above 2.5 mmol/l if their serum silicon concentra-plasma silicon concentration in these latter patients on regular haemodialysis was similar to tap water. In the tion was above 150 mmol/l, although this did not reach statistical significance. Thus high serum silicon concen-Roberts study the silicon and aluminium concentrations in the plasma of 41 patients were not correlated trations may help protect patients from the adverse effects of aluminium levels higher than 2.5 mmol/l that [6 ] , but these patients did use dialysate prepared with reverse osmosis. have been described previously [11] . It has been suggested from studies of aluminium toxicity to fish [4] We did observe, however, that there was no evidence of aluminium related disease in London and that strong interactions between aluminium and silicon require a critical silicon concentration of equal to or Portsmouth (high drinking water silicon) but small numbers with this diagnosis in Liverpool and Leeds greater than 100 mmol/l in water-our study investigated serum concentrations.
( low drinking water silicon). The patients in the London group with high serum aluminiums Dialysis patients are potentially exposed to aluminium and silicon via two major routes: the dialysate (>4 mmol/l ) all had serum silicon concentrations of 100-150 mmol/l, i.e. above the critical minimum silicon and the gastrointestinal tract. With the increased use of reverse osmosis, this type of water used for dialysate concentration, and therefore may have been protected from possible toxic effects of elevated aluminium. preparation contains negligible amounts of silicon and aluminium. Gastrointestinal exposure to aluminium is These findings suggest that a serum concentration of silicon-around 100 mmol/l-may exert a protective also much reduced with the reduction in use of aluminium-containing phosphate binders. Exposure to alu-effect against aluminium accumulation and toxicity, in-keeping with previous animal studies [4, 5] . A high minium and silicon is therefore mainly through food and drinking water, although occasionally dialysate concentration of silicon in the blood appears of itself to have no ill effects. contamination may still occur [12] . Apart from the theoretical grounds [1, 3] and animal studies suggesting
Further work needs to be done to confirm that silicon, as these findings suggest, plays a preventative beneficial effects of silicon, there is evidence that silicon in water limits the enteral absorption of aluminium role both in the accumulation of aluminium and in aluminium related disease in dialysis patients. The from both food and water in man [13] and rats [14] , although more recently this has been questioned in possibility of applying this to therapeutic use by increasing the oral intake of silicon should be considfurther rat studies [15] . One might expect, therefore, a reciprocal relationship between silicon and aluminium ered, for example, to reduce absorption and consequent toxicity of aluminium from aluminium-containing levels in dialysis patients if the sole or principal route of absorption is enteral. Thus, patients with very high phosphate binders and other dietary sources. serum silicon concentrations had lower aluminium levels inferring either a reduced intestinal absorption Acknowledgements. The authors thank E. Sieniawaska for excellent technical assistance.
or increased removal of aluminium through dialysis, by the formation of an aluminium-silicon complex. We would not, however, wish to suggest a potential benefit from the use of non-reverse osmosis treated water for References the preparation of dialysate, as reverse osmosis is the Dobbie and Smith [7] in 1986 looked at silicon levels 3. Birchall JD. The toxicity of aluminium and the effect of silicon in uraemic individuals. They found uraemic patients on its bioavailability. In: Nicotini M, Zatta PF, Corain B ed.
had significantly higher serum silicon levels than 
